143 related articles for article (PubMed ID: 11393173)
1. Plasma drug levels compared with DNA incorporation of 3'-azido-3'-deoxythymidine (AZT) in adult cynomolgus (Macaca fascicularis) monkeys.
Olivero OA; Reddy MK; Pietras SM; Poirier MC
Exp Biol Med (Maywood); 2001 May; 226(5):446-9. PubMed ID: 11393173
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of 3'-azido-3'-deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose.
Poirier MC; Patterson TA; Slikker W; Olivero OA
J Acquir Immune Defic Syndr; 1999 Dec; 22(5):477-83. PubMed ID: 10961609
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.
Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Baker R; Stek AM; Khoury MM; Poirier MC
Ann N Y Acad Sci; 2000 Nov; 918():262-8. PubMed ID: 11131712
[TBL] [Abstract][Full Text] [Related]
4. Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.
Meng Q; Olivero OA; Fasco MJ; Bellisario R; Kaminsky L; Pass KA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Bigbee WL; O'Neill JP; Walker DM; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):307-21. PubMed ID: 17358024
[TBL] [Abstract][Full Text] [Related]
5. 3'-azido-3'-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT.
Olivero OA; Parikka R; Poirier MC; Vähäkangas K
Mutat Res; 1999 Jul; 428(1-2):41-7. PubMed ID: 10517977
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.
Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Landay AL; Baker R; Stek AM; Khoury MM; Proia LA; Kessler HA; Sha BE; Tarone RE; Poirier MC
AIDS; 1999 May; 13(8):919-25. PubMed ID: 10371172
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel (32)P-postlabeling method for the analysis of 3'-azido-3'-deoxythymidine.
Fang JL; Beland FA
Cancer Lett; 2000 May; 153(1-2):25-33. PubMed ID: 10779626
[TBL] [Abstract][Full Text] [Related]
9. In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice.
Chow HH; Li P; Brookshier G; Tang Y
Drug Metab Dispos; 1997 Apr; 25(4):412-22. PubMed ID: 9107539
[TBL] [Abstract][Full Text] [Related]
10. 3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeys.
Boudinot FD; Schinazi RF; Gallo JM; McClure HM; Anderson DC; Doshi KJ; Kambhampathi PC; Chu CK
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):219-28. PubMed ID: 2328158
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice.
Parang K; Wiebe LI; Knaus EE
J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
Good SS; Koble CS; Crouch R; Johnson RL; Rideout JL; de Miranda P
Drug Metab Dispos; 1990; 18(3):321-6. PubMed ID: 1974193
[TBL] [Abstract][Full Text] [Related]
13. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
Sommadossi JP; Carlisle R; Zhou Z
Mol Pharmacol; 1989 Jul; 36(1):9-14. PubMed ID: 2747633
[TBL] [Abstract][Full Text] [Related]
14. Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes.
Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Xie MY; Rahmani R; Schinazi RF; Duchin K; Sommadossi JP
Antimicrob Agents Chemother; 1997 Nov; 41(11):2502-10. PubMed ID: 9371357
[TBL] [Abstract][Full Text] [Related]
15. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion.
Patterson TA; Binienda ZK; Lipe GW; Gillam MP; Slikker W; Sandberg JA
Drug Metab Dispos; 1997 Apr; 25(4):453-9. PubMed ID: 9107545
[TBL] [Abstract][Full Text] [Related]
16. Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.
Olivero OA; Anderson LM; Diwan BA; Haines DC; Harbaugh SW; Moskal TJ; Jones AB; Rice JM; Riggs CW; Logsdon D; Yuspa SH; Poirier MC
J Natl Cancer Inst; 1997 Nov; 89(21):1602-8. PubMed ID: 9362158
[TBL] [Abstract][Full Text] [Related]
17. Effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (zidovudine) in human mononuclear cells.
Szebeni J; Patel SS; Hung K; Wahl LM; Weinstein JN
Antimicrob Agents Chemother; 1991 Jan; 35(1):198-200. PubMed ID: 2014977
[TBL] [Abstract][Full Text] [Related]
18. Comparative metabolism of 3'-azido-3'-deoxythymidine in cultured hepatocytes from rats, dogs, monkeys, and humans.
Nicolas F; De Sousa G; Thomas P; Placidi M; Lorenzon G; Rahmani R
Drug Metab Dispos; 1995 Mar; 23(3):308-13. PubMed ID: 7628294
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.
Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP
Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160
[TBL] [Abstract][Full Text] [Related]
20. Relationships between DNA incorporation, mutant frequency, and loss of heterozygosity at the TK locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine.
Meng Q; Su T; Olivero OA; Poirier MC; Shi X; Ding X; Walker VE
Toxicol Sci; 2000 Apr; 54(2):322-9. PubMed ID: 10774814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
